Partnering with Microchips
We believe the versatility and unique functional aspects of our proprietary platform lend itself to enhance the clinical utility and commercial value of a wide range of established and novel therapeutics.
Our business strategy consists of advancing the development of our own microchip-based applications, while seeking strategic partners to augment our commercialization efforts and collaborate on the development of innovative therapies utilizing our breakthrough drug delivery platform.
To explore potential partnership opportunities, please contact firstname.lastname@example.org.
In 2012, we received grants from the Bill & Melinda Gates Foundation to develop a long-acting, reversible microchip-based contraceptive implant for women in developing countries who have limited access to routine medical care and modern contraceptive options. The program is still ongoing.